A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Journal of Neurological Sciences

• Publication date

  1983-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0022-510X(83)90200-9PMID 6142096
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statistical analysis of enzyme kinetic data.

  2006cited by this paper
• Pick's disease with compound intraneuronal inclusion bodies

  2004cited by this paper
• A post-mortem study of the cholinergic and GABA systems in senile dementia.

  1982cited by this paper
• Pick's Disease: A Clinical, Computed Tomographic, and Histologic Study With Golgi Impregnation Observations

  1982cited by this paper
• Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients.

  1982cited by this paper
• Reduced lumbar CSF somatostatin levels in Alzheimer's disease.

  1982cited by this paper
• Reduced cortical choline acetyltransferase activity in Gerstmann-Sträussler syndrome.

  1982cited by this paper
• Age at onset of Pick's and Alzheimer's dementia: implications for diagnosis and research.

  1982cited by this paper
• Cholinergic innervation in neuritic plaques.

  1982cited by this paper
• Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.

  1981cited by this paper
• Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

  1981cited by this paper
• Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa

  1980cited by this paper
• Dementia of the Alzheimer type.

  1980cited by this paper
• Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type.

  1980cited by this paper
• Neurochemical observations in a case of Pick's disease.

  1980cited by this paper
• Topography of Pick inclusion bodies in hippocampi of demented patients. A quantitative study.

  1979cited by this paper
• Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.

  1978cited by this paper
• The binding of agonists to brain muscarinic receptors.

  1978cited by this paper
• Pre- and postsynaptic neurochemical alterations in Alzheimer's disease.

  1978cited by this paper
• Selective vulnerability of neurones in organic dementia

  1977cited by this paper
• Neocortical cholinergic neurons in elderly people.

  1977cited by this paper
• Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains.

  1977cited by this paper
• Necropsy evidence of central cholinergic deficits in senile dementia.

  1977cited by this paper
• Selective loss of central cholinergic neurons in Alzheimer's disease.

  1976cited by this paper
• Pick's disease. Histological and clinical correlations.

  1974cited by this paper
• Pick’s Disease

  1974cited by this paper
• Muscarinic cholinergic binding in rat brain.

  1974cited by this paper
• Pick's Disease: A Clinical and Ultrastructural Study

  1972cited by this paper
• [Absolute number of nerve cells and thickness of the cerebral cortex during aging and in disease (senile and vascular dementia, Pick's and Alzheimer's diseases)].

  1972cited by this paper
• Aspects of the pathology of presenile dementia.

  1970cited by this paper
• ASPECTS OF THE PATHOLOGY OF PRESENILE DEMENTIA

  1970cited by this paper
• Radiochemical micro assays for the determination of choline acetyltransferase and acetylcholinesterase activities.

  1969cited by this paper
• The statistical analysis of enzyme kinetic data.

  1967cited by this paper
• Cerebral Biopsy in the Investigation of Presenile Dementia

  1966cited by this paper
• Cerebral Biopsy in the Investigation of Presenile Dementia

  1966cited by this paper
• Alzheimer's neurofibrillary changes. A topographic study.

  1962cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Loss of Cholinergic Receptor Muscarinic 1 (CHRM1) Protein in the Hippocampus and Temporal Cortex of a Subset of Individuals with Alzheimer’s Disease, Parkinson’s Disease, or Frontotemporal Dementia: Implications for Patient Survival

  2022cites this paper
• Basal forebrain cholinergic system in the dementias: Vulnerability, resilience, and resistance

  2021cites this paper
• Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study

  2020cites this paper
• Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs

  2019cites this paper
• Professional Profile

  2018cites this paper
• Neurotransmitter deficits from frontotemporal lobar degeneration

  2018cites this paper
• University of Groningen Muscarinic Cholinoceptive Neurons in the Frontal Cortex in Alzheimer ’ s Disease

  2017cites this paper
• Higher levels of different muscarinic receptors in the cortex and hippocampus from subjects with Alzheimer’s disease

  2017cites this paper
• Les modifications neurochimiques pathologiques qui surviennent dans le cerveau lors du vieillissement et au cours des démences

  2016cites this paper
• The Handbook Of Alzheimer's Disease And Other Dementias (Softcover)

  2013cites this paper
• Medical Management of Frontotemporal Dementias: The Importance of the Caregiver in Symptom Assessment and Guidance of Treatment Strategies

  2011cites this paper
• Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options.

  2011cites this paper
• Frontotemporal lobar degeneration

  2010cites this paper
• Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.

  2010cites this paper
• A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia

  2006cites this paper
• Adenosine A2A Receptors are Up‐regulated in Pick’s Disease Frontal Cortex

  2006cites this paper
• Increased CSF HVA response to arecoline challenge in Alzheimer's disease

  2005cites this paper
• Neurodegenerative und verwandte Erkrankungen

  2005cites this paper
• Neurodegenerative Diseases: Frontotemporal lobar degeneration

  2005cites this paper
• Functional neurochemistry of Alzheimer's disease.

  2004cites this paper
• Decreased Cerebrospinal Fluid Acetylcholinesterase in Patients with Subcortical Ischemic Vascular Dementia

  2003cites this paper
• Alterations of muscarinic acetylcholine receptors in atypical Pick’s disease without Pick bodies

  2003cites this paper
• Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study.

  2003cites this paper
• Frontotemporal Dementia: Paroxetine as a Possible Treatment of Behavior Symptoms

  2002cites this paper
• Actualización sobre la patología de la enfermedad de Alzheimer

  2002cites this paper
• Neuropathology of Pick’s disease

  2001cites this paper
• Frontotemporal dementia: evidence for impairment of ascending serotoninergic but not noradrenergic innervation

  2001cites this paper
• The Anatomy of Dementias

  1999cites this paper
• Functional imaging, the frontal lobes, and dementia.

  1998cites this paper
• Pick's Disease: A Modern Approach

  1998cites this paper
• Nontoxic amyloid beta peptide 1-42 suppresses acetylcholine synthesis. Possible role in cholinergic dysfunction in Alzheimer's disease.

  1997cites this paper
• The cholinergic system in Alzheimer's disease.

  1997cites this paper
• Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease

  1997cites this paper
• The neurochemistry of Alzheimer type, vascular type and mixed type dementias compared.

  1996cites this paper
• Effects of freezing storage time on the density of muscarinic receptors in the human postmortem brain: an autoradiographic study in control and Alzheimer's disease brain tissues.

  1996cites this paper
• Studies on the amyloid precursor protein : implication for Alzheimer's disease.

  1996cites this paper
• Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.

  1996cites this paper
• Nerve Growth Factor and Alzheimer's Disease

  1994cites this paper
• Pick’s Disease

  1994cites this paper
• Neurochemical and Histopathologic Alterations Characteristic of Pick's Disease in a Non-demented Individual

  1994cites this paper
• Intermediary metabolism disturbance in AD/SDAT and its relation to molecular events.

  1993cites this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1 beta or IL-1RA but increases in the associated acute phase proteins IL-6, alpha 2-macroglobulin and C-reactive protein.

  1993cites this paper
• Cytokine indices in Alzheimer's temporal cortex: no changes in mature IL-1β or IL-1RA but increases in the associated acute phase proteins IL-6, α2-macroglobulin and C-reactive protein

  1993cites this paper
• Preliminary neurochemical findings in non-Alzheimer dementia due to lobar atrophy.

  1993cites this paper
• The potential for muscarinic receptor subtype-specific pharmacotherapy for Alzheimer's disease.

  1991cites this paper
• Altered serotonergic and cholinergic synaptic markers in Pick's disease.

  1991cites this paper
• Parvalbumin-immunoreactive neurons in the cortex in Pick's disease

  1991cites this paper
• Coupling of ml Muscarinic Receptors to G Protein in Alzheimer Disease

  1991cites this paper
• Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease.

  1991cites this paper
• Changes of muscarinic cholinergic binding by lymphocytes in parkinson's disease with and without dementia

  1991cites this paper
• IMMUNOCYTOCHEMISTRY OF MUSCARINIC AND NICOTINIC RECEPTORS IN HUMAN BRAIN

  1991cites this paper
• Cholinergic receptors in human brain: Effects of aging and alzheimer disease

  1990cites this paper
• Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients.

  1989cites this paper
• Monoaminergic neurotransmitters in Alzheimer's disease. An HPLC study comparing presenile familial and sporadic senile cases.

  1989cites this paper
• The cholinergic receptor system of the human brain: neurochemical and pharmacological aspects in aging and Alzheimer.

  1989cites this paper
• A brain regional analysis of morphologic and cholinergic abnormalities in Alzheimer's disease.

  1989cites this paper
• Evolution of neurotransmitter receptor systems.

  1988cites this paper
• Neocortical morphometry and cholinergic neurochemistry in Pick's disease.

  1988cites this paper
• Muscarinic Acetylcholine Receptors

  1988cites this paper
• The Cholinergic Receptor System in the Frontal Lobe of Alzheimer Patients

  1988cites this paper
• Differential modification of muscarinic cholinergic receptors in the hippocampus of patients with Alzheimer's disease: an autoradiographic study.

  1988cites this paper
• Basal Forebrain Cholinergic Neurons and Alzheimer’s Disease

  1988cites this paper
• Neurochemical Studies in Dementia

  1988cites this paper
• Bilateral symmetry of cholinergic deficits in Alzheimer's disease.

  1988cites this paper
• Cholinesterase and its molecular forms in pathological states.

  1988cites this paper
• Neuropathological and Neurochemical Aspects of Alzheimer’s Disease

  1988cites this paper
• Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease

  1988cites this paper
• Studies on neurotransmitter markers of the basal ganglia in Pick's disease, with special reference to dopamine reduction.

  1988cites this paper
• Reduced somatostatin‐like immunoreactivity in cerebral cortex in nonfamilial dysphasic dementia

  1987cites this paper
• Selective changes in mu, delta and kappa opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients.

  1987cites this paper
• Selective changes in μ, δ and ϰ opioid receptor binding in certain limbic regions of the brain in Alzheimer's disease patients

  1987cites this paper
• Decreased somatostatin-like immunoreactivity in cerebral cortex and cerebrospinal fluid in Alzheimer's disease.

  1987cites this paper
• Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.

  1987cites this paper
• Cholinergic and GABAergic neurotoxicity of some alkylating agents.

  1986cites this paper
• Dementia in Movement Disorders

  1986cites this paper
• Prospective strategies for cholinergic interventions in Alzheimer's disease.

  1986cites this paper
• Characterization of l‐[3H]Nicotine Binding in Human Cerebral Cortex: Comparison Between Alzheimer's Disease and the Normal

  1986cites this paper
• Klüver‐Bucy syndrome and amyotrophic lateral sclerosis

  1986cites this paper
• Neuropeptides and dementia.

  1986cites this paper
• Cortical Degeneration with Swollen Chromatolytic Neurons: Its Relationship to Pick's Disease

  1986cites this paper
• Cholinergic receptors in aging and Alzheimer's disease.

  1986cites this paper
• [Cholinergic treatment strategies in Alzheimer's disease].

  1986cites this paper
• Distribution of the molecular forms of acetylcholinesterase in human brain: Alterations in dementia of the Alzheimer type

  1986cites this paper
• Two Drug Binding Sites on Muscarinic Receptors

  1986cites this paper
• Brain Nicotinic and Muscarinic Receptors in Normal Aging and Dementia

  1986cites this paper
• Neurotransmitter and Receptor Deficits in Senile Dementia of the Alzheimer Type

  1986cites this paper
• Non-cholinergic neurotransmitter abnormalities in Alzheimer's disease.

  1986cites this paper
• Primary Degenerative Dementia Without Alzheimer Pathology

  1986cites this paper
• Antemortem laboratory diagnosis of Alzheimer's disease

  1986cites this paper
• Neurotransmitter deficits in Alzheimer's disease and in other dementing disorders.

  1986cites this paper
• The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.

  1986cites this paper
• Somatostatin in the central nervous system: physiology and pathological modifications.

  1986cites this paper
• Memory Function and Brain Biochemistry in Normal Aging and in Senile Dementia

  1985cites this paper
• Transmitter deficits in Alzheimer's disease.

  1985cites this paper
• Loss of M2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation.

  1985cites this paper
• Somatostatin alterations and brain diseases.

  1985cites this paper
• Transmitter deficits in Alzheimer's disease.

  1985cites this paper